[go: up one dir, main page]

FR2450251B1 - - Google Patents

Info

Publication number
FR2450251B1
FR2450251B1 FR8004573A FR8004573A FR2450251B1 FR 2450251 B1 FR2450251 B1 FR 2450251B1 FR 8004573 A FR8004573 A FR 8004573A FR 8004573 A FR8004573 A FR 8004573A FR 2450251 B1 FR2450251 B1 FR 2450251B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR8004573A
Other versions
FR2450251A1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ono Pharmaceutical Co Ltd
Original Assignee
Ono Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP2257179A external-priority patent/JPS55115865A/ja
Priority claimed from JP2257279A external-priority patent/JPS55115863A/ja
Application filed by Ono Pharmaceutical Co Ltd filed Critical Ono Pharmaceutical Co Ltd
Publication of FR2450251A1 publication Critical patent/FR2450251A1/fr
Application granted granted Critical
Publication of FR2450251B1 publication Critical patent/FR2450251B1/fr
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/18—Sulfonamides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • A61K31/24—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group having an amino or nitro group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • A61K31/24—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group having an amino or nitro group
    • A61K31/245—Amino benzoic acid types, e.g. procaine, novocaine

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Emergency Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR8004573A 1979-03-01 1980-02-29 Derives de l'acide guanidinobenzoique, procede pour leur preparation et compositions pharmaceutiques les contenant Granted FR2450251A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2257179A JPS55115865A (en) 1979-03-01 1979-03-01 Guanidinobenzoic acid derivative and its preparation
JP2257279A JPS55115863A (en) 1979-03-01 1979-03-01 Guanidinobenzoic acid derivative and its preparation

Publications (2)

Publication Number Publication Date
FR2450251A1 FR2450251A1 (fr) 1980-09-26
FR2450251B1 true FR2450251B1 (fr) 1983-02-18

Family

ID=26359810

Family Applications (1)

Application Number Title Priority Date Filing Date
FR8004573A Granted FR2450251A1 (fr) 1979-03-01 1980-02-29 Derives de l'acide guanidinobenzoique, procede pour leur preparation et compositions pharmaceutiques les contenant

Country Status (4)

Country Link
US (1) US4283418A (fr)
DE (1) DE3005580A1 (fr)
FR (1) FR2450251A1 (fr)
GB (1) GB2044760B (fr)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4423069A (en) * 1982-01-20 1983-12-27 University Of Illinois Foundation Contraceptive method
DE3429114A1 (de) * 1984-08-03 1986-02-13 Schering AG, 1000 Berlin und 4709 Bergkamen Substituierte guanidinobenzoesaeurephenylester, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
US4746737A (en) * 1985-07-26 1988-05-24 Kowa Co., Ltd. Phenyl guanidinobenzoate derivatives which have protease inhibitory activity
US5247084A (en) * 1985-11-12 1993-09-21 Ono Pharmaceutical Co., Ltd. Derivatives of p-guanidinobenzoic acid
DE3681408D1 (fr) * 1985-11-12 1991-10-17 Ono Pharmaceutical Co. Ltd., Osaka, Jp
US4843094A (en) * 1985-11-12 1989-06-27 Ono Pharmaceutical Co., Ltd. Derivatives of p-guantidinobenzoic acid and pharmaceutical agents containing them as active ingredient
JPH0676373B2 (ja) * 1985-12-27 1994-09-28 エーザイ株式会社 グアニジノ安息香酸エステル誘導体
US6388122B1 (en) 1996-04-10 2002-05-14 Ono Pharmaceutical Co., Ltd. Tryptase inhibitor and novel guanidino derivatives
US6849605B1 (en) * 1999-03-05 2005-02-01 The Trustees Of University Technology Corporation Inhibitors of serine protease activity, methods and compositions for treatment of viral infections
AU3511500A (en) 1999-03-05 2000-09-21 Trustees Of University Technology Corporation, The Inhibitors of serine protease activity, methods and compositions for treatment of nitric oxide-induced clinical conditions
WO2000051625A1 (fr) * 1999-03-05 2000-09-08 The Trustees Of University Technology Corporation Inhibiteurs d'activite de serine protease, methodes et compositions de traitement de virus de l'herpes
US20040220242A1 (en) * 2003-05-02 2004-11-04 Leland Shapiro Inhibitors of serine protease activity, methods and compositions for treatment of nitric oxide induced clinical conditions
EP3192872A1 (fr) 2003-08-26 2017-07-19 The Regents of the University of Colorado, a body corporate Inhibiteurs de l'activité de sérine protéase et leur utilisation dans les procédés et compositions pour le traitement des infections bactériennes
CA2656161A1 (fr) * 2006-07-26 2008-01-31 Teva Pharmaceutical Industries Ltd. Procede pour synthetiser le compose o-desmethylvenlafaxine
EP2539313A2 (fr) * 2010-03-29 2013-01-02 Pliva Hrvatska D.O.O. Formes cristallines du fumarate de o-desméthylvenlafaxine
KR102103476B1 (ko) 2011-06-24 2020-04-23 더 리젠츠 오브 더 유니버시티 오브 콜로라도, 어 바디 코포레이트 알파-1 안티트립신 융합 분자용 조성물, 방법 및 용도
EA025164B1 (ru) * 2011-09-15 2016-11-30 Астеллас Фарма Инк. Соединение гуанидинобензойной кислоты
AU2013202648B2 (en) 2012-01-10 2016-05-19 Konkuk University Compositions, methods and uses for alpha-1 antitrypsin fusion molecules
CN114805141A (zh) * 2021-01-27 2022-07-29 中国科学院上海药物研究所 4-胍基苯甲酸芳基酯类化合物及其在抗SARS-CoV-2病毒中的用途

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1905813A1 (de) * 1968-07-04 1970-03-05 Akad Wissenschaften Ddr 3- oder 4-Guanidobenzoesaeurebenzyl- oder -phenylestern und deren Verwendung als Inhibitoren
GB1472700A (en) * 1974-11-01 1977-05-04 Ono Pharmaceutical Co Guanidinobehzoic acid derivatives and process for preparing the same
JPS5470241A (en) 1977-11-09 1979-06-05 Ono Pharmaceut Co Ltd Guanidinobenzoic acid derivative and its preparation

Also Published As

Publication number Publication date
GB2044760A (en) 1980-10-22
DE3005580C2 (fr) 1988-12-22
DE3005580A1 (de) 1980-09-11
FR2450251A1 (fr) 1980-09-26
US4283418A (en) 1981-08-11
GB2044760B (en) 1983-03-23

Similar Documents

Publication Publication Date Title
FR2449889B1 (fr)
FR2449780B1 (fr)
FR2448664B1 (fr)
FR2450660B1 (fr)
BR8002583A (fr)
FR2450251B1 (fr)
BR8006808A (fr)
FR2450646B1 (fr)
FR2449969B1 (fr)
FR2446913B1 (fr)
FR2446153B1 (fr)
FR2449589B1 (fr)
FR2448427B1 (fr)
FR2448716B1 (fr)
FR2448159B3 (fr)
FR2448002B1 (fr)
FR2446171B3 (fr)
FR2446331B1 (fr)
FR2449893B1 (fr)
FR2449570B1 (fr)
FR2447640B1 (fr)
FR2446749B1 (fr)
FR2446240B1 (fr)
FR2449788B1 (fr)
FR2447910B2 (fr)

Legal Events

Date Code Title Description
ST Notification of lapse